Home
This site is intended for healthcare professionals

Obstructive Sleep Apnea Care Pathways: Clinical Summary

A concise clinical summary addressing key learning objectives for translating cardiometabolic risk into longitudinal OSA management.

This program is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals globally excluding the UK.

Clinical Risk Identification: Dr. Kirsch

  • Clinicians must look beyond classic symptoms like snoring and witnessed apneas to identify high-risk cardiometabolic comorbidities, including treatment-resistant hypertension, type 2 diabetes, atrial fibrillation, and heart failure.
  • Critical non-classic "red flags" that should prompt an OSA evaluation include morning headaches, nocturia, unexplained fatigue, brain fog, and depression.
  • Women frequently experience underdiagnosis because they present with atypical symptoms such as insomnia, fatigue, nightmares, and mood disturbances rather than classical gasping or sleepiness.